Screening and Testing to Detect Cancer: Prostate Cancer
Researchers are working on developing effective methods to screen for prostate cancer. However, it has not yet been shown that screening for prostate cancer decreases the chances of dying from prostate cancer.
On this page:
Prostate-Specific Antigen (PSA)
Prostate-Specific Antigen (PSA) Test
A fact sheet that describes the PSA screening test for prostate cancer and explains the benefits and limitations of the test.
Find Clinical Trials to Screen for Prostate Cancer
Check for prostate cancer screening trials from NCI's list of cancer clinical trials now accepting patients. The list of clinical trials can be refined by location and other features.
Research About Prostate Cancer Screening
Long-Term Trial Results Show No Mortality Benefit from Annual Prostate Cancer Screening
Thirteen year follow-up data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial show higher incidence but similar mortality among men screened annually with the prostate-specific antigen (PSA) test and digital rectal examination (DRE).
Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
A large-scale clinical trial to determine whether certain cancer screening tests reduce deaths from prostate, lung, colorectal, and ovarian cancer. In addition, there are numerous epidemiologic and ancillary studies going on that will answer other crucial questions about these cancers and these screening tests.
Prostate Changes and Conditions